Evidence map›Paper›PMID 40746500›Full record

ArticleJCEM case reports2025

A Rare Coexistence of Thyrotropin-Secreting Pituitary Adenoma and Graves Disease.

Yuichi Oda, Kosaku Amano, Yasufumi Seki, Daisuke Watanabe, Atsuhiro Ichihara, Takakazu Kawamata

Abstract readCase Reports
In one paragraph

Article in JCEM case reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Yuichi OdaDepartment of Neurosurgery, Tokyo Women's Medical University, Shinjuku-ku, Tokyo 162-8666, Japan.ORCID https://orcid.org/0009-0006-3294-6812
Kosaku AmanoDepartment of Neurosurgery, Tokyo Women's Medical University, Shinjuku-ku, Tokyo 162-8666, Japan.ORCID https://orcid.org/0000-0002-5589-4852
Yasufumi SekiDepartment of Medicine, Division of Hormonal Medicine and Bioregulatory Science, Tokyo Women's Medical University, Shinjuku-ku, Tokyo 162-8666, Japan.ORCID https://orcid.org/0000-0002-1950-7704
Daisuke WatanabeDepartment of Medicine, Division of Hormonal Medicine and Bioregulatory Science, Tokyo Women's Medical University, Shinjuku-ku, Tokyo 162-8666, Japan.ORCID https://orcid.org/0000-0002-6526-829X
Atsuhiro IchiharaDepartment of Medicine, Division of Hormonal Medicine and Bioregulatory Science, Tokyo Women's Medical University, Shinjuku-ku, Tokyo 162-8666, Japan.ORCID https://orcid.org/0000-0002-3872-9767
Takakazu KawamataDepartment of Neurosurgery, Tokyo Women's Medical University, Shinjuku-ku, Tokyo 162-8666, Japan.ORCID https://orcid.org/0000-0002-6076-7065

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The coexistence of Graves disease (GD) and a thyroid-stimulating hormone (TSH)-secreting pituitary adenoma (TSHoma) is a rare and diagnostically challenging condition. In general, GD typically manifests with low TSH because of excess thyroid hormone production; contrastingly, a TSHoma causes secondary hyperthyroidism with normal or elevated TSH levels. This unusual overlap poses diagnostic and therapeutic challenges; therefore, a careful approach is required to distinguish and manage both conditions. We present the case of a 51-year-old woman with symptoms of hyperthyroidism, elevated thyroid hormones, low TSH, and positive anti-TSH receptor antibodies, which were suggestive of GD 10 years prior. After stopping thiamazole and levothyroxine because of the favorable control of thyroid function 6 months prior, the patient presented a syndrome of inappropriate secretion of TSH and magnetic resonance imaging revealed a pituitary macroadenoma; accordingly, she was diagnosed with concurrent GD and a TSHoma. Treatment involved transsphenoidal resection of the TSHoma and antithyroid medication to control GD. This case illustrates the rarity of coexisting GD and TSHoma and the diagnostic and therapeutic complexities of managing dual hyperthyroidism etiologies. Biochemical testing, antibody assessment, and imaging examination are essential for accurate and early diagnosis of the condition.

Indexed as

diagnosisGraves diseasehyperthyroidismthyrotroph pituitary adenoma

Identifiers

PMID40746500
PMCPMC12311426

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.